Patrick Hargutt
Fondateur chez Stanley Capital Partners LLP
Profil
Patrick Hargutt founded Stanley Capital Partners LLP in 2020, where he is working as Founding Partner from 2020.
Mr. Hargutt also currently works at Stanley Lab, Inc., as Founding Director from 2021, Laboratoire X.O, as Board Director from 2022, and Noden Pharma DAC, as Director from 2020.
Mr. Hargutt also formerly worked at Healthcare AI Acquisition Corp., as Chief Financial Officer & Director and Monarch Alternative Capital (Private Equity), as Vice President from 2018 to 2019.
Mr. Hargutt received his undergraduate degree in 2010 from Technische Universität München.
Postes actifs de Patrick Hargutt
| Sociétés | Poste | Début |
|---|---|---|
Stanley Capital Partners LLP
 Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Fondateur | 01/01/2020 |
Noden Pharma DAC
 Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Directeur/Membre du Conseil | 01/09/2020 |
Laboratoire X.O
 Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Directeur/Membre du Conseil | 01/09/2022 |
| Stanley Lab, Inc. | Directeur/Membre du Conseil | 01/03/2021 |
Anciens postes connus de Patrick Hargutt
| Sociétés | Poste | Fin |
|---|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Directeur Financier/CFO | 12/06/2023 |
Monarch Alternative Capital (Private Equity)
 Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Private Equity Investor | 31/10/2019 |
Formation de Patrick Hargutt
| Technische Universität München | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Finance |
| Entreprise privées | 5 |
|---|---|
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Finance |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Health Technology |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Health Technology |
| Stanley Lab, Inc. | |
Monarch Alternative Capital (Private Equity)
Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Finance |